DSE : SAMORITA
Samorita Hospital Limited — Key statistics
Hospitals · Bangladesh
Last price 84.7 BDT (At close: Oct 29, 2026) · Market cap 1.85B
Latest research: Samorita Hospital financial analysis: 3.4% net margin, land is 74% of assets, qualified audit (Oct 2026) · Samorita Hospital: revenue BDT 401.4m in FY2025, land BDT 884.3m on the balance sheet, FY2026 EPS BDT 1.12
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.85B |
| Enterprise Value | 1.77B |
Dates
| Measure | Value |
|---|
| Earnings Date | Jan 25, 2027 |
| Ex-Dividend Date | Nov 18, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 21.80M |
| Shares Outstanding | 21.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -4.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Ratios
| Measure | Value |
|---|
| PE Ratio | 172.10 |
| Forward PE | n/a |
| PS Ratio | 4.33 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | 92.31 |
| P/OCF Ratio | 40.07 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 165.12 |
| EV / Sales | 4.15 |
| EV / EBITDA | 40.94 |
| EV / EBIT | 96.47 |
| EV / FCF | 88.57 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.57 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.20 |
| Interest Coverage | 7.40 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.01% |
| Return on Assets (ROA) | 0.94% |
| Return on Invested Capital (ROIC) | 0.91% |
| Return on Capital Employed (ROCE) | 1.59% |
| Weighted Average Cost of Capital (WACC) | 3.69% |
| Revenue Per Employee | 738,020 |
| Profits Per Employee | 18,563 |
| Employee Count | 578 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 8.39 |
Taxes
| Measure | Value |
|---|
| Income Tax | 10.41M |
| Effective Tax Rate | 49.24% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.11 |
| 52-Week Price Change | +15.24% |
| 50-Day Moving Average | 93.44 |
| 200-Day Moving Average | 80.03 |
| Relative Strength Index (RSI) | 42.40 |
| Average Volume (20 Days) | 196,538 |
Shortselling
| Measure | Value |
|---|
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Incomestatement
| Measure | Value |
|---|
| Revenue | 426.58M |
| Gross Profit | 247.88M |
| Operating Income | 18.25M |
| Pretax Income | 21.14M |
| Net Income | 10.73M |
| EBITDA | 42.24M |
| EBIT | 18.25M |
| Earnings Per Share (EPS) | 0.49 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 47.94M |
| Total Debt | 3.93M |
| Net Cash | 44.01M |
| Net Cash Per Share | 2.02 |
| Equity (Book Value) | 1.06B |
| Book Value Per Share | 48.67 |
| Working Capital | 37.52M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 46.09M |
| Capital Expenditures | -26.08M |
| Depreciation & Amortization | 24.00M |
| Net Borrowing | -7.37M |
| Free Cash Flow | 20.00M |
| FCF Per Share | 0.92 |
Margins
| Measure | Value |
|---|
| Gross Margin | 58.11% |
| Operating Margin | 4.28% |
| Pretax Margin | 4.95% |
| Profit Margin | 2.52% |
| EBITDA Margin | 9.90% |
| EBIT Margin | 4.28% |
| FCF Margin | 4.69% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.59% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 101.60% |
| FCF Payout Ratio | 108.99% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.59% |
| Earnings Yield | 0.58% |
| FCF Yield | 1.08% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 10, 2023 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 6.31 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |